ARSD, arylsulfatase D, 414

N. diseases: 163; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Anxiety is common in children with ASD; however, the burden of specific anxiety disorders for adults with ASD is under-researched. 31621020 2020
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE Anxiety disorders were more common in full siblings and half-siblings of people with ASD.The implications of this are explored. 31621020 2020
CUI: C0018817
Disease: Atrial Septal Defects
Atrial Septal Defects
0.100 GeneticVariation group BEFREE We aimed to develop and internally validate a scoring system, the adult spinal deformity surgical decision-making (ASD-SDM) score, to guide the decision-making process for ASD patients aged above 40 years. 31317308 2020
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.100 Biomarker disease BEFREE The lack of any association, when considered with positive findings seen in ASD and schizophrenia, and negative findings in bipolar disorder suggests different pathways linking maternal immune activation and development of various neuropsychiatric disorders. 31312974 2020
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.100 Biomarker disease BEFREE Using a functional genomics approach, we integrated transcriptomic data from the developing human brain, genome-wide association findings for SCZ and ASD, protein interaction data, and gene expression signatures from SCZ and ASD postmortem cortex to 1) organize genes into the developmental cellular and molecular systems within which they operate, 2) identify neurodevelopmental processes associated with polygenic risk for SCZ and ASD across the allelic frequency spectrum, and 3) elucidate pathways and individual genes through which 22q11.2 copy number variants may confer risk for each disorder. 31500805 2020
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.100 Biomarker phenotype BEFREE Parenting Strategies Used by Parents of Children with ASD: Differential Links with Child Problem Behaviour. 31676915 2020
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.100 Biomarker phenotype BEFREE Children with ASD often display behavior problems that can lead to academic and social disruptions. 31676916 2020
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.100 Biomarker phenotype BEFREE We studied the possible preventive effect of the methyl donor for epigenetic enzymatic reactions, S-adenosine methionine (SAM), on ASD like behavioral changes and on redox potential in the brain and liver in this model. 29343446 2020
CUI: C0524528
Disease: Pervasive Development Disorder
Pervasive Development Disorder
0.100 Biomarker group BEFREE The aim of this study is to investigate the association between prematurity and diagnosis of neurodevelopmental disorders (ND) (attention deficit/hyperactivity disorder [ADHD] or autism spectrum disorder [ASD]) in Brazilian children and adolescents. 31552529 2020
CUI: C0524528
Disease: Pervasive Development Disorder
Pervasive Development Disorder
0.100 GeneticVariation group BEFREE Familial disorders with onset in childhood (e.g., autism spectrum disorder [ASD]) are promising targets for presymptomatic prediction; however, little is known about parent perceptions of risk to their children in the presymptomatic period. 31764985 2020
Attention deficit hyperactivity disorder
0.100 Biomarker disease BEFREE The aim of this study is to investigate the association between prematurity and diagnosis of neurodevelopmental disorders (ND) (attention deficit/hyperactivity disorder [ADHD] or autism spectrum disorder [ASD]) in Brazilian children and adolescents. 31552529 2020
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.100 GeneticVariation disease BEFREE Familial disorders with onset in childhood (e.g., autism spectrum disorder [ASD]) are promising targets for presymptomatic prediction; however, little is known about parent perceptions of risk to their children in the presymptomatic period. 31764985 2020
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.100 GeneticVariation disease BEFREE We aimed to develop and internally validate a scoring system, the adult spinal deformity surgical decision-making (ASD-SDM) score, to guide the decision-making process for ASD patients aged above 40 years. 31317308 2020
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.100 Biomarker disease BEFREE The aim of this study is to investigate the association between prematurity and diagnosis of neurodevelopmental disorders (ND) (attention deficit/hyperactivity disorder [ADHD] or autism spectrum disorder [ASD]) in Brazilian children and adolescents. 31552529 2020
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.100 GeneticVariation disease BEFREE The findings of this study suggest that the aforementioned five reported ASD genes and JAK2 and MAPK7 may be related to ASD susceptibility. 31838722 2020
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.100 Biomarker disease BEFREE Using a functional genomics approach, we integrated transcriptomic data from the developing human brain, genome-wide association findings for SCZ and ASD, protein interaction data, and gene expression signatures from SCZ and ASD postmortem cortex to 1) organize genes into the developmental cellular and molecular systems within which they operate, 2) identify neurodevelopmental processes associated with polygenic risk for SCZ and ASD across the allelic frequency spectrum, and 3) elucidate pathways and individual genes through which 22q11.2 copy number variants may confer risk for each disorder. 31500805 2020
CUI: C1862389
Disease: ATRIAL SEPTAL DEFECT 1
ATRIAL SEPTAL DEFECT 1
0.100 GeneticVariation disease BEFREE We aimed to develop and internally validate a scoring system, the adult spinal deformity surgical decision-making (ASD-SDM) score, to guide the decision-making process for ASD patients aged above 40 years. 31317308 2020
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.100 Biomarker group BEFREE Anxiety disorders were diagnosed in 20.1% of adults with ASD compared with 8.7% of controls (RR = 2.62 [95% CI 2.47-2.79]), with greatest risk for autistic people without intellectual disability. 31621020 2020
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE As to anxiety, it is not the main characteristics of ASD, but represents one of the most common its co morbidities. 31437571 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Group differences in brain activation disappeared when either alexithymia or anxiety - both elevated in the ASD group - were controlled for. 29683406 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Symptoms of ASD were found to influence elevated levels of parent-rated GAD indirectly through greater levels of sensory avoiding, and auditory-specific sensory behaviours correlated with parent-rated anxiety more strongly than other sensory modalities. 30771129 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE There was no significant difference in risks for ADHD (OR = 1.563; 95% CI, 1.382-1.769); sleep disorders (OR = 2.100; 95% CI, 1.322-3.336); anxiety (OR = 1.339; 95% CI, 1.062-1.687); depression (OR = 1.402 95% CI, 1.256-1.565); conduct disorder (OR = 1.494 95% CI, 1.230-1.815); or ASD (OR = 2.574; 95% CI, 1.469-4.510; <i>Q</i><sub>b</sub> = 8.344, <i>p</i> = 0.138). 31447731 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Our findings emphasise the need to provide timely assessment and treatment of anxiety and depression in ASD. 31190198 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Maternal anxiety or depression was associated with 2.7 times the odds (95% confidence interval: 1.4, 5.3) of Type 4 or Dysregulated ASD in the child; maternal anxiety and depression was associated with 4.4 times the odds (95% confidence interval: 1.4, 14.0) of Type 4 or Dysregulated ASD in the child. 30128718 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE As expected, many of these include animal model equivalents of the "core" phenotypes associated with ASD, such as impairments in social behavior and repetitive behavior, as well as several comorbid features of ASD including anxiety, seizures, and motor-control deficits. 30911366 2019